Eton Pharmaceuticals Inc (ETON)
3.63
+0.08
(+2.25%)
USD |
NASDAQ |
Jun 03, 16:00
3.60
-0.03
(-0.83%)
After-Hours: 20:00
Eton Pharmaceuticals Revenue (TTM): 34.30M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 34.30M |
December 31, 2023 | 31.64M |
September 30, 2023 | 32.83M |
June 30, 2023 | 29.02M |
March 31, 2023 | 24.38M |
December 31, 2022 | 21.25M |
September 30, 2022 | 18.85M |
June 30, 2022 | 16.40M |
Date | Value |
---|---|
March 31, 2022 | 12.11M |
December 31, 2021 | 21.83M |
September 30, 2021 | 15.82M |
June 30, 2021 | 14.88M |
March 31, 2021 | 11.84M |
December 31, 2020 | 0.039M |
September 30, 2020 | 0.417M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.039M
Minimum
Dec 2020
34.30M
Maximum
Mar 2024
19.04M
Average
18.85M
Median
Sep 2022
Revenue (TTM) Benchmarks
Eli Lilly and Co | 35.93B |
Evoke Pharma Inc | 6.106M |
Outlook Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 14.23M |
Palatin Technologies Inc | -- |